Article
Multidrug-resistant conjugative plasmid carrying mphA confers increased antimicrobial resistance in Shigella
23 Mar 2024
Abstract excerpt
Shigellosis remains a common gastrointestinal disease mostly in children < 5 years of age in developing countries. Azithromycin (AZM), a macrolide, is currently the first-line treatment for shigellosis in Bangladesh; ciprofloxacin (CIP) and ceftriaxone (CRO) are also used frequently. We aimed to evaluate the current epidemiology of antimicrobial resistance (AMR) and mechanism(s) of increasing macrolide resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
